Niki BioSolutions, Inc. (NIKI) Return on Capital Employed (2025)
Niki BioSolutions' (NIKI) quarterly Return on Capital Employed came in at 64.01% in Q4 2025, up 60.14% on a QoQ basis from 160.57% in Q3 2025.
Niki BioSolutions, Inc. (NIKI) Return on Capital Employed (2025) Analysis & Trends
Niki BioSolutions (NIKI) has 1 years of Return on Capital Employed data on file, last reported at 64.01% in Q4 2025.
- Quarterly Return on Capital Employed changed N/A year-over-year to 64.01% in Q4 2025, while the trailing twelve-month figure through Nov 2025 was 64.01% (changed N/A YoY) and the FY2025 annual result came in at 8.1%, down 377.0% from the prior year.
- Return on Capital Employed climbed to 64.01% in Q4 2025, from 160.57% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 64.01% in Q4 2025 to a low of 160.57% in Q3 2025.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | -64.01% |
| Aug 31, 2025 | -160.57% |